249 related articles for article (PubMed ID: 22503792)
1. Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.
Fofana I; Fafi-Kremer S; Carolla P; Fauvelle C; Zahid MN; Turek M; Heydmann L; Cury K; Hayer J; Combet C; Cosset FL; Pietschmann T; Hiet MS; Bartenschlager R; Habersetzer F; Doffoël M; Keck ZY; Foung SKH; Zeisel MB; Stoll-Keller F; Baumert TF
Gastroenterology; 2012 Jul; 143(1):223-233.e9. PubMed ID: 22503792
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.
Fauvelle C; Felmlee DJ; Crouchet E; Lee J; Heydmann L; Lefèvre M; Magri A; Hiet MS; Fofana I; Habersetzer F; Foung SK; Milne R; Patel AH; Vercauteren K; Meuleman P; Zeisel MB; Bartenschlager R; Schuster C; Baumert TF
Gastroenterology; 2016 Jan; 150(1):206-217.e4. PubMed ID: 26404951
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
Haberstroh A; Schnober EK; Zeisel MB; Carolla P; Barth H; Blum HE; Cosset FL; Koutsoudakis G; Bartenschlager R; Union A; Depla E; Owsianka A; Patel AH; Schuster C; Stoll-Keller F; Doffoël M; Dreux M; Baumert TF
Gastroenterology; 2008 Nov; 135(5):1719-1728.e1. PubMed ID: 18718838
[TBL] [Abstract][Full Text] [Related]
4. Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.
Guan M; Wang W; Liu X; Tong Y; Liu Y; Ren H; Zhu S; Dubuisson J; Baumert TF; Zhu Y; Peng H; Aurelian L; Zhao P; Qi Z
J Biol Chem; 2012 Oct; 287(42):35631-35645. PubMed ID: 22927442
[TBL] [Abstract][Full Text] [Related]
5. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.
Fofana I; Xiao F; Thumann C; Turek M; Zona L; Tawar RG; Grunert F; Thompson J; Zeisel MB; Baumert TF
PLoS One; 2013; 8(5):e64221. PubMed ID: 23704981
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
Fafi-Kremer S; Fauvelle C; Felmlee DJ; Zeisel MB; Lepiller Q; Fofana I; Heydmann L; Stoll-Keller F; Baumert TF
Viruses; 2012 Oct; 4(10):2016-30. PubMed ID: 23202451
[TBL] [Abstract][Full Text] [Related]
7. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.
Fafi-Kremer S; Fofana I; Soulier E; Carolla P; Meuleman P; Leroux-Roels G; Patel AH; Cosset FL; Pessaux P; Doffoël M; Wolf P; Stoll-Keller F; Baumert TF
J Exp Med; 2010 Aug; 207(9):2019-31. PubMed ID: 20713596
[TBL] [Abstract][Full Text] [Related]
8. Virus-neutralizing antibodies to hepatitis C virus.
Wahid A; Dubuisson J
J Viral Hepat; 2013 Jun; 20(6):369-76. PubMed ID: 23647953
[TBL] [Abstract][Full Text] [Related]
9. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.
Prentoe J; Bukh J
Front Immunol; 2018; 9():2146. PubMed ID: 30319614
[TBL] [Abstract][Full Text] [Related]
10. Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection.
Wrensch F; Ligat G; Heydmann L; Schuster C; Zeisel MB; Pessaux P; Habersetzer F; King BJ; Tarr AW; Ball JK; Winkler M; Pöhlmann S; Keck ZY; Foung SKH; Baumert TF
Hepatology; 2019 Nov; 70(5):1506-1520. PubMed ID: 31062385
[TBL] [Abstract][Full Text] [Related]
11. A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.
Urbanowicz RA; McClure CP; Brown RJ; Tsoleridis T; Persson MA; Krey T; Irving WL; Ball JK; Tarr AW
J Virol; 2015 Dec; 90(7):3288-301. PubMed ID: 26699643
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
14. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
15. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
[TBL] [Abstract][Full Text] [Related]
16. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
[TBL] [Abstract][Full Text] [Related]
17. Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp).
Bailey JR; Urbanowicz RA; Ball JK; Law M; Foung SKH
Methods Mol Biol; 2019; 1911():441-450. PubMed ID: 30593644
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus evasion mechanisms from neutralizing antibodies.
Lorenzo CD; Angus AGN; Patel AH
Viruses; 2011 Nov; 3(11):2280-2300. PubMed ID: 22163345
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
20. Molecular Determinants of Mouse Adaptation of Rat Hepacivirus.
Wolfisberg R; Holmbeck K; Billerbeck E; Thorselius CE; Batista MN; Fahnøe U; Lundsgaard EA; Kennedy MJ; Nielsen L; Rice CM; Bukh J; Scheel TKH
J Virol; 2023 Apr; 97(4):e0181222. PubMed ID: 36971565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
